Back to top

Image: Bigstock

Xeris' Shares March Higher, Can It Continue?

Read MoreHide Full Article

As of late, it has definitely been a great time to be an investor in Xeris Pharmaceuticals, Inc. (XERS - Free Report) . The stock has moved higher by 2% in the past month, while it is also above its 20 Day SMA too. This combination of strong price performance and favorable technical, could suggest that the stock may be on the right path.

We certainly think that this might be the case, particularly if you consider XERS’ recent earnings estimate revision activity. From this look, the company’s future is quite favorable; as XERS has earned itself a Zacks Rank #2 (Buy), meaning that its recent run may continue for a bit longer, and that this isn’t the top for the in-focus company. You can see the complete list of today’s Zacks #1 Rank stocks here.

5 Stocks Set to Double

Each was hand-picked by a Zacks expert as the #1 favorite stock to gain +100% or more in 2020. Each comes from a different sector and has unique qualities and catalysts that could fuel exceptional growth.

Most of the stocks in this report are flying under Wall Street radar, which provides a great opportunity to get in on the ground floor.

Today, See These 5 Potential Home Runs >>


See More Zacks Research for These Tickers


Normally $25 each - click below to receive one report FREE:


Xeris Biopharma Holdings, Inc. (XERS) - free report >>

Published in